The role of basic-fibroblast growth factor (b-FGF) in cyclosporine-induced nephrotoxicity

In Vivo. 2006 Mar-Apr;20(2):265-9.

Abstract

Background: The effect of the b-fibroblast growth factor (b-FGF) on cyclosporine A (CsA)-induced nephrotoxicity in the rat kidney was investigated.

Materials and methods: The rats were divided into six groups: A (control), B (b-FGF-treated), C, D: (CsA-treated and sacrificed on days 14 or 21), E, F (Cs A- and b-FGF- treated and sacrificed on days 14 or 21). The antibody mouse anti-rat CD31 was used to evaluate the kidney vessels present in histological preparations.

Results: The kidney vessels in group B were increased in comparison with the control group (p<0.05). Reduction of kidney vessels in groups C and D (p<0.05) in comparison with the controls was observed, while in groups E and F they were increased when compared to group C (p<0.05) and D (p<0.05), respectively.

Conclusion: The angiogenic role of b-FGF was confirmed in normal rats and a possible "protective" role of b-FGF was shown in rat kidney with CsA-induced nephrotoxicity.

MeSH terms

  • Animals
  • Blood Vessels / drug effects
  • Blood Vessels / pathology
  • Cyclosporine / toxicity*
  • Drug Antagonism
  • Drug Therapy, Combination
  • Fibroblast Growth Factor 2 / metabolism
  • Fibroblast Growth Factor 2 / pharmacology*
  • Immunosuppressive Agents / toxicity*
  • Injections, Intramuscular
  • Kidney / blood supply
  • Kidney / drug effects*
  • Kidney Diseases / chemically induced
  • Kidney Diseases / metabolism*
  • Kidney Diseases / pathology
  • Male
  • Neovascularization, Physiologic / drug effects*
  • Neovascularization, Physiologic / physiology
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Immunosuppressive Agents
  • Fibroblast Growth Factor 2
  • Cyclosporine